Revotar Biopharmaceuticals
Latest round
- Series A
Last raised
- Sep 2008
Total raised
- $15M
Investors
- 4
About Revotar Biopharmaceuticals
Revotar Biopharmaceuticals AG is a Germany-based biopharmaceutical company focused on developing innovative therapeutic solutions targeting serious medical conditions.Revotar Biopharmaceuticals AG operates in Hennigsdorf, Germany, and specializes in biopharmaceutical development.Revotar specializes in innovative technology solutions aimed at enhancing user experience and operational efficiency. Their core product offerings include a suite of software applications designed for data analytics and process automation, which cater to businesses seeking to streamline their operations. These applications are particularly beneficial for industries requiring robust data management and insightful analytics, such as finance, healthcare, and logistics. The company’s products have been released over the past few years, with a focus on continuous improvement and integration of the latest technological advancements.Revotar's revenue model is structured around B2B transactions, primarily through subscription-based services and partnerships with key industry players. Clients typically engage with the firm through annual subscriptions that provide access to their suite of software solutions, ensuring continuous support and updates. The pricing plans are designed to accommodate a range of business sizes, with tailored packages that allow companies to select features that best meet their operational needs. Flagship products within their portfolio are instrumental in driving revenue, as they provide significant value to clients aiming to leverage data for strategic decision-making.Revotar Biopharmaceuticals AG is focusing on designing and launching new products aimed at enhancing their therapeutic solutions, although specific release dates have not been disclosed. The company plans to expand its operations into new markets, particularly targeting regions in Eastern Europe and North America by 2025.
Who invested in Revotar Biopharmaceuticals
4 investors across 2 rounds
See all investors in Revotar Biopharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Revotar Biopharmaceuticals
Who invested in Revotar Biopharmaceuticals?
Revotar Biopharmaceuticals has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Revotar Biopharmaceuticals raised?
Revotar Biopharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Revotar Biopharmaceuticals last raise money?
Revotar Biopharmaceuticals's most recent round on record is a Series A, in Sep 2008.
What does Revotar Biopharmaceuticals do?
Revotar Biopharmaceuticals AG is a Germany-based biopharmaceutical company focused on developing innovative therapeutic solutions targeting serious medical conditions.
Where is Revotar Biopharmaceuticals headquartered?
Revotar Biopharmaceuticals is headquartered in Hennigsdorf, Germany.
Which VCs invest in companies like Revotar Biopharmaceuticals?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Revotar Biopharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Revotar Biopharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.